Loading…
Trimethylamine-N-Oxide: A Carnitine-Derived Metabolite That Prolongs the Hypertensive Effect of Angiotensin II in Rats
Abstract Background Recent evidence suggests that an elevated plasma trimethylamine N-oxide (TMAO) level is associated with an increased risk of adverse cardiovascular events in humans; however, the mechanism is not clear. The aims of this study were to establish the plasma TMAO level in rats and to...
Saved in:
Published in: | Canadian journal of cardiology 2014-12, Vol.30 (12), p.1700-1705 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c411t-826941cf3cf2cc65afbd589109750065fc57c180822a49812cc9a53fbc527f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c411t-826941cf3cf2cc65afbd589109750065fc57c180822a49812cc9a53fbc527f3 |
container_end_page | 1705 |
container_issue | 12 |
container_start_page | 1700 |
container_title | Canadian journal of cardiology |
container_volume | 30 |
creator | Ufnal, Marcin, PhD, MD Jazwiec, Radoslaw, MSc Dadlez, Michal, PhD Drapala, Adrian, MD Sikora, Mariusz, MD Skrzypecki, Janusz, MD |
description | Abstract Background Recent evidence suggests that an elevated plasma trimethylamine N-oxide (TMAO) level is associated with an increased risk of adverse cardiovascular events in humans; however, the mechanism is not clear. The aims of this study were to establish the plasma TMAO level in rats and to evaluate the effect of TMAO on arterial blood pressure (BP) and the hemodynamic effects of angiotensin II (Ang II). Methods Twelve-week-old, Sprague-Dawley rats were implanted with telemetric transmitters, and continuous recordings of heart rate, systolic BP (SBP), and diastolic BP (DBP) were made for 7 days before and 14 days during osmotic minipump-driven subcutaneous infusion of saline (controls), TMAO, low-dose Ang II, or Ang II + TMAO. Plasma TMAO concentration was evaluated using liquid chromatography coupled with triple-quadrupole mass spectrometry. Results The plasma TMAO concentration in controls was 0.57 μmol/L, whereas in TMAO-infused rats it was 58 μmol/L. Neither saline nor TMAO infusion affected SBP and DBP. Infusion of Ang II significantly increased SBP and DBP for the first 5 days of infusion only. In contrast, infusion of Ang II + TMAO produced a hypertensive response that lasted until the end of the experiment. TMAO infusions did not affect body weight and motor activity. Conclusions We showed that physiological plasma TMAO concentration in rats was approximately 10 times lower than that reported in humans. Furthermore, the new finding of the study is that TMAO does not affect BP in normotensive animals. However, it prolongs the hypertensive effect of Ang II. |
doi_str_mv | 10.1016/j.cjca.2014.09.010 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1634273177</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0828282X14013634</els_id><sourcerecordid>1634273177</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-826941cf3cf2cc65afbd589109750065fc57c180822a49812cc9a53fbc527f3</originalsourceid><addsrcrecordid>eNp9kc1uEzEURi0EoqHwAiyQl2xm8PX8I4QUhUIjFYpoFuwsx3PdeJjYwXaq5m36LH0yPKSwYIFkydLV-T7pnkvIS2A5MKjfDLkalMw5gzJnXc6APSIz6KDOGtZUj8mMtbzNeMu_n5BnIQyMldA09VNywquySQ9m5HblzRbj5jDKrbGYfckub02Pb-mcLqS3Jk7DD-jNDfb0M0a5dqOJSFcbGelX70ZnrwONG6Tnhx36iDYklJ5pjSpSp-ncXhv3e2zpcnl_Z-z93TcZw3PyRMsx4IuH_5RcfTxbLc6zi8tPy8X8IlMlQMxaXnclKF0ozZWqK6nXfdV2wLqmYqyutKoaBW3alMuyayFBnawKvVYVb3RxSl4fW3fe_dxjiGJrgsJxlBbdPgioi5I3RdKSUH5ElXcheNRil9RIfxDAxORbDGLyLSbfgnUi-U6hVw_9-_UW-7-RP4IT8O4IYNrxxqAXQRm0CnvjkyHRO_P__vf_xNVorFFy_IEHDIPbe5vsCRCBCyaupotPB4eSQZF2K34BfJaoBA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1634273177</pqid></control><display><type>article</type><title>Trimethylamine-N-Oxide: A Carnitine-Derived Metabolite That Prolongs the Hypertensive Effect of Angiotensin II in Rats</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Ufnal, Marcin, PhD, MD ; Jazwiec, Radoslaw, MSc ; Dadlez, Michal, PhD ; Drapala, Adrian, MD ; Sikora, Mariusz, MD ; Skrzypecki, Janusz, MD</creator><creatorcontrib>Ufnal, Marcin, PhD, MD ; Jazwiec, Radoslaw, MSc ; Dadlez, Michal, PhD ; Drapala, Adrian, MD ; Sikora, Mariusz, MD ; Skrzypecki, Janusz, MD</creatorcontrib><description>Abstract Background Recent evidence suggests that an elevated plasma trimethylamine N-oxide (TMAO) level is associated with an increased risk of adverse cardiovascular events in humans; however, the mechanism is not clear. The aims of this study were to establish the plasma TMAO level in rats and to evaluate the effect of TMAO on arterial blood pressure (BP) and the hemodynamic effects of angiotensin II (Ang II). Methods Twelve-week-old, Sprague-Dawley rats were implanted with telemetric transmitters, and continuous recordings of heart rate, systolic BP (SBP), and diastolic BP (DBP) were made for 7 days before and 14 days during osmotic minipump-driven subcutaneous infusion of saline (controls), TMAO, low-dose Ang II, or Ang II + TMAO. Plasma TMAO concentration was evaluated using liquid chromatography coupled with triple-quadrupole mass spectrometry. Results The plasma TMAO concentration in controls was 0.57 μmol/L, whereas in TMAO-infused rats it was 58 μmol/L. Neither saline nor TMAO infusion affected SBP and DBP. Infusion of Ang II significantly increased SBP and DBP for the first 5 days of infusion only. In contrast, infusion of Ang II + TMAO produced a hypertensive response that lasted until the end of the experiment. TMAO infusions did not affect body weight and motor activity. Conclusions We showed that physiological plasma TMAO concentration in rats was approximately 10 times lower than that reported in humans. Furthermore, the new finding of the study is that TMAO does not affect BP in normotensive animals. However, it prolongs the hypertensive effect of Ang II.</description><identifier>ISSN: 0828-282X</identifier><identifier>EISSN: 1916-7075</identifier><identifier>DOI: 10.1016/j.cjca.2014.09.010</identifier><identifier>PMID: 25475471</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Angiotensin II - adverse effects ; Animals ; Blood Pressure - drug effects ; Cardiovascular ; Chromatography, High Pressure Liquid ; Disease Models, Animal ; Hypertension - metabolism ; Hypertension - physiopathology ; Male ; Methylamines - pharmacokinetics ; Oxidants - pharmacology ; Rats ; Rats, Sprague-Dawley</subject><ispartof>Canadian journal of cardiology, 2014-12, Vol.30 (12), p.1700-1705</ispartof><rights>Canadian Cardiovascular Society</rights><rights>2014 Canadian Cardiovascular Society</rights><rights>Copyright © 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-826941cf3cf2cc65afbd589109750065fc57c180822a49812cc9a53fbc527f3</citedby><cites>FETCH-LOGICAL-c411t-826941cf3cf2cc65afbd589109750065fc57c180822a49812cc9a53fbc527f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25475471$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ufnal, Marcin, PhD, MD</creatorcontrib><creatorcontrib>Jazwiec, Radoslaw, MSc</creatorcontrib><creatorcontrib>Dadlez, Michal, PhD</creatorcontrib><creatorcontrib>Drapala, Adrian, MD</creatorcontrib><creatorcontrib>Sikora, Mariusz, MD</creatorcontrib><creatorcontrib>Skrzypecki, Janusz, MD</creatorcontrib><title>Trimethylamine-N-Oxide: A Carnitine-Derived Metabolite That Prolongs the Hypertensive Effect of Angiotensin II in Rats</title><title>Canadian journal of cardiology</title><addtitle>Can J Cardiol</addtitle><description>Abstract Background Recent evidence suggests that an elevated plasma trimethylamine N-oxide (TMAO) level is associated with an increased risk of adverse cardiovascular events in humans; however, the mechanism is not clear. The aims of this study were to establish the plasma TMAO level in rats and to evaluate the effect of TMAO on arterial blood pressure (BP) and the hemodynamic effects of angiotensin II (Ang II). Methods Twelve-week-old, Sprague-Dawley rats were implanted with telemetric transmitters, and continuous recordings of heart rate, systolic BP (SBP), and diastolic BP (DBP) were made for 7 days before and 14 days during osmotic minipump-driven subcutaneous infusion of saline (controls), TMAO, low-dose Ang II, or Ang II + TMAO. Plasma TMAO concentration was evaluated using liquid chromatography coupled with triple-quadrupole mass spectrometry. Results The plasma TMAO concentration in controls was 0.57 μmol/L, whereas in TMAO-infused rats it was 58 μmol/L. Neither saline nor TMAO infusion affected SBP and DBP. Infusion of Ang II significantly increased SBP and DBP for the first 5 days of infusion only. In contrast, infusion of Ang II + TMAO produced a hypertensive response that lasted until the end of the experiment. TMAO infusions did not affect body weight and motor activity. Conclusions We showed that physiological plasma TMAO concentration in rats was approximately 10 times lower than that reported in humans. Furthermore, the new finding of the study is that TMAO does not affect BP in normotensive animals. However, it prolongs the hypertensive effect of Ang II.</description><subject>Angiotensin II - adverse effects</subject><subject>Animals</subject><subject>Blood Pressure - drug effects</subject><subject>Cardiovascular</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Disease Models, Animal</subject><subject>Hypertension - metabolism</subject><subject>Hypertension - physiopathology</subject><subject>Male</subject><subject>Methylamines - pharmacokinetics</subject><subject>Oxidants - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><issn>0828-282X</issn><issn>1916-7075</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kc1uEzEURi0EoqHwAiyQl2xm8PX8I4QUhUIjFYpoFuwsx3PdeJjYwXaq5m36LH0yPKSwYIFkydLV-T7pnkvIS2A5MKjfDLkalMw5gzJnXc6APSIz6KDOGtZUj8mMtbzNeMu_n5BnIQyMldA09VNywquySQ9m5HblzRbj5jDKrbGYfckub02Pb-mcLqS3Jk7DD-jNDfb0M0a5dqOJSFcbGelX70ZnrwONG6Tnhx36iDYklJ5pjSpSp-ncXhv3e2zpcnl_Z-z93TcZw3PyRMsx4IuH_5RcfTxbLc6zi8tPy8X8IlMlQMxaXnclKF0ozZWqK6nXfdV2wLqmYqyutKoaBW3alMuyayFBnawKvVYVb3RxSl4fW3fe_dxjiGJrgsJxlBbdPgioi5I3RdKSUH5ElXcheNRil9RIfxDAxORbDGLyLSbfgnUi-U6hVw_9-_UW-7-RP4IT8O4IYNrxxqAXQRm0CnvjkyHRO_P__vf_xNVorFFy_IEHDIPbe5vsCRCBCyaupotPB4eSQZF2K34BfJaoBA</recordid><startdate>20141201</startdate><enddate>20141201</enddate><creator>Ufnal, Marcin, PhD, MD</creator><creator>Jazwiec, Radoslaw, MSc</creator><creator>Dadlez, Michal, PhD</creator><creator>Drapala, Adrian, MD</creator><creator>Sikora, Mariusz, MD</creator><creator>Skrzypecki, Janusz, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20141201</creationdate><title>Trimethylamine-N-Oxide: A Carnitine-Derived Metabolite That Prolongs the Hypertensive Effect of Angiotensin II in Rats</title><author>Ufnal, Marcin, PhD, MD ; Jazwiec, Radoslaw, MSc ; Dadlez, Michal, PhD ; Drapala, Adrian, MD ; Sikora, Mariusz, MD ; Skrzypecki, Janusz, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-826941cf3cf2cc65afbd589109750065fc57c180822a49812cc9a53fbc527f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Angiotensin II - adverse effects</topic><topic>Animals</topic><topic>Blood Pressure - drug effects</topic><topic>Cardiovascular</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Disease Models, Animal</topic><topic>Hypertension - metabolism</topic><topic>Hypertension - physiopathology</topic><topic>Male</topic><topic>Methylamines - pharmacokinetics</topic><topic>Oxidants - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ufnal, Marcin, PhD, MD</creatorcontrib><creatorcontrib>Jazwiec, Radoslaw, MSc</creatorcontrib><creatorcontrib>Dadlez, Michal, PhD</creatorcontrib><creatorcontrib>Drapala, Adrian, MD</creatorcontrib><creatorcontrib>Sikora, Mariusz, MD</creatorcontrib><creatorcontrib>Skrzypecki, Janusz, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Canadian journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ufnal, Marcin, PhD, MD</au><au>Jazwiec, Radoslaw, MSc</au><au>Dadlez, Michal, PhD</au><au>Drapala, Adrian, MD</au><au>Sikora, Mariusz, MD</au><au>Skrzypecki, Janusz, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trimethylamine-N-Oxide: A Carnitine-Derived Metabolite That Prolongs the Hypertensive Effect of Angiotensin II in Rats</atitle><jtitle>Canadian journal of cardiology</jtitle><addtitle>Can J Cardiol</addtitle><date>2014-12-01</date><risdate>2014</risdate><volume>30</volume><issue>12</issue><spage>1700</spage><epage>1705</epage><pages>1700-1705</pages><issn>0828-282X</issn><eissn>1916-7075</eissn><abstract>Abstract Background Recent evidence suggests that an elevated plasma trimethylamine N-oxide (TMAO) level is associated with an increased risk of adverse cardiovascular events in humans; however, the mechanism is not clear. The aims of this study were to establish the plasma TMAO level in rats and to evaluate the effect of TMAO on arterial blood pressure (BP) and the hemodynamic effects of angiotensin II (Ang II). Methods Twelve-week-old, Sprague-Dawley rats were implanted with telemetric transmitters, and continuous recordings of heart rate, systolic BP (SBP), and diastolic BP (DBP) were made for 7 days before and 14 days during osmotic minipump-driven subcutaneous infusion of saline (controls), TMAO, low-dose Ang II, or Ang II + TMAO. Plasma TMAO concentration was evaluated using liquid chromatography coupled with triple-quadrupole mass spectrometry. Results The plasma TMAO concentration in controls was 0.57 μmol/L, whereas in TMAO-infused rats it was 58 μmol/L. Neither saline nor TMAO infusion affected SBP and DBP. Infusion of Ang II significantly increased SBP and DBP for the first 5 days of infusion only. In contrast, infusion of Ang II + TMAO produced a hypertensive response that lasted until the end of the experiment. TMAO infusions did not affect body weight and motor activity. Conclusions We showed that physiological plasma TMAO concentration in rats was approximately 10 times lower than that reported in humans. Furthermore, the new finding of the study is that TMAO does not affect BP in normotensive animals. However, it prolongs the hypertensive effect of Ang II.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>25475471</pmid><doi>10.1016/j.cjca.2014.09.010</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0828-282X |
ispartof | Canadian journal of cardiology, 2014-12, Vol.30 (12), p.1700-1705 |
issn | 0828-282X 1916-7075 |
language | eng |
recordid | cdi_proquest_miscellaneous_1634273177 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Angiotensin II - adverse effects Animals Blood Pressure - drug effects Cardiovascular Chromatography, High Pressure Liquid Disease Models, Animal Hypertension - metabolism Hypertension - physiopathology Male Methylamines - pharmacokinetics Oxidants - pharmacology Rats Rats, Sprague-Dawley |
title | Trimethylamine-N-Oxide: A Carnitine-Derived Metabolite That Prolongs the Hypertensive Effect of Angiotensin II in Rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T09%3A44%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trimethylamine-N-Oxide:%20A%20Carnitine-Derived%20Metabolite%20That%20Prolongs%20the%20Hypertensive%20Effect%20of%20Angiotensin%20II%C2%A0in%C2%A0Rats&rft.jtitle=Canadian%20journal%20of%20cardiology&rft.au=Ufnal,%20Marcin,%20PhD,%20MD&rft.date=2014-12-01&rft.volume=30&rft.issue=12&rft.spage=1700&rft.epage=1705&rft.pages=1700-1705&rft.issn=0828-282X&rft.eissn=1916-7075&rft_id=info:doi/10.1016/j.cjca.2014.09.010&rft_dat=%3Cproquest_cross%3E1634273177%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c411t-826941cf3cf2cc65afbd589109750065fc57c180822a49812cc9a53fbc527f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1634273177&rft_id=info:pmid/25475471&rfr_iscdi=true |